Skip to main content
SpringerLink
Log in

Do We Need Heart Teams for Complex Cardiac Arrhythmias? A Cardiologist’s Perspective

  • Chapter
  • First Online:
Heart Teams for Treatment of Cardiovascular Disease

Abstract

In many academic cardiovascular centers, there has been a long-standing tradition of collaboration in the management of patients with complex arrhythmias. More recently, there have been initiatives at our institution and others to extend this further, i.e., create a formal “heart team” approach. The ultimate goal is to provide high-quality, evidence-based, timely, cost-effective, personalized care to patients with complex arrhythmias. This chapter will review three areas where the heart team has a key role in the management of complex cardiac arrhythmias:

  1. (i)

    Atrial fibrillation

  2. (ii)

    Ventricular arrhythmias

  3. (iii)

    Inherited arrhythmia syndromes (IAS)

The complex arrhythmia heart team approach has already been shown to be cost-effective in a number of areas. The hope is that the concept of the “complex arrhythmia heart team” will continue to evolve and grow at our institution and others. Going forward, we hope to convince healthcare administrators and funders that savings achieved by the team should, at least in part, be directed to support the team. In the meantime, we will continue to focus on our ultimate goal to provide high-quality, evidence-based, timely, cost-effective, personalized care to patients with complex arrhythmias.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fumagalli S, Chen J, Dobreanu D, Madrid AH, Tilz R, Dagres N. The role of the arrhythmia team, an integrated, multidisciplinary approach to treatment of patients with cardiac arrhythmias: results of the European Heart Rhythm Association survey. Europace. 2016;18(4):623–7.

    Article  PubMed  Google Scholar 

  2. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837–47.

    Article  PubMed  Google Scholar 

  3. Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112(8):1142–7.

    Article  PubMed  Google Scholar 

  4. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–962.

    Article  PubMed  Google Scholar 

  5. Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478–86.

    Article  CAS  PubMed  Google Scholar 

  6. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14(10):e275–444.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Berti D, Hendriks JM, Brandes A, Deaton C, Crijns HJ, Camm AJ, et al. A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice. Eur Heart J. 2013;34(35):2725–30.

    Article  PubMed  Google Scholar 

  8. Nieuwlaat R, Olsson SB, Lip GY, Camm AJ, Breithardt G, Capucci A, et al. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. Am Heart J. 2007;153(6):1006–12.

    Article  CAS  PubMed  Google Scholar 

  9. Vizel’ AA, Nasretdinova GR, Islamova LV, Vizel’ EA. [Evaluation of the efficiency of various treatment regimens for patients with newly-detected sarcoidosis in the Republic of Tatarstan]. Probl Tuberk Bolezn Legk. 2006(4):19–23. [Article in Russian].

    Google Scholar 

  10. Al-Mallah MH, Farah I, Al-Madani W, Bdeir B, Al Habib S, Bigelow ML, et al. The impact of nurse-led clinics on the mortality and morbidity of patients with cardiovascular diseases: a systematic review and meta-analysis. J Cardiovasc Nurs. 2016;31(1):89–95.

    Article  PubMed  Google Scholar 

  11. Watanabe H, Chinushi M, Izumi D, Sato A, Okada S, Okamura K, et al. Decrease in amplitude of intracardiac ventricular electrogram and inappropriate therapy in patients with an implantable cardioverter defibrillator. Int Heart J. 2006;47(3):363–70.

    Article  PubMed  Google Scholar 

  12. Il’kovich MM, Perlei VE, Amosov VI, Lebedeva EV. [Early diagnosis of pulmonary hemodynamic disorders in patients with pulmonary sarcoidosis]. Probl Tuberk Bolezn Legk. 2006(4):45–50. [Article in Russian].

    Google Scholar 

  13. Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet. 2014;384(9943):583–90.

    Article  PubMed  Google Scholar 

  14. Hendriks JM, de Wit R, Crijns HJ, Vrijhoef HJ, Prins MH, Pisters R, et al. Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. Eur Heart J. 2012;33(21):2692–9.

    Article  PubMed  Google Scholar 

  15. Hendriks JM, Vrijhoef HJ, Crijns HJ, Brunner-La Rocca HP. The effect of a nurse-led integrated chronic care approach on quality of life in patients with atrial fibrillation. Europace. 2014;16(4):491–9.

    Article  PubMed  Google Scholar 

  16. Hendriks J, Tomini F, van Asselt T, Crijns H, Vrijhoef H. Cost-effectiveness of a specialized atrial fibrillation clinic vs. usual care in patients with atrial fibrillation. Europace. 2013;15(8):1128–35.

    Article  PubMed  Google Scholar 

  17. Stewart S, Ball J, Horowitz JD, Marwick TH, Mahadevan G, Wong C, et al. Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial. Lancet. 2015;385(9970):775–84.

    Article  PubMed  Google Scholar 

  18. Gronefeld GC, Hohnloser SH. Quality of life in atrial fibrillation: an increasingly important issue. Eur Heart J Suppl. 2003;5:H25–33.

    Article  Google Scholar 

  19. Healey JS, Parkash R, Pollak T, Tsang T, Dorian P, Committee CCSAFG. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: etiology and initial investigations. Can J Cardiol. 2011;27(1):31–7.

    Article  PubMed  Google Scholar 

  20. Dabrowski R, Smolis-Bak E, Kowalik I, Kazimierska B, Wojcicka M, Szwed H. Quality of life and depression in patients with different patterns of atrial fibrillation. Kardiol Pol. 2010;68(10):1133–9.

    PubMed  Google Scholar 

  21. Ariansen I, Dammen T, Abdelnoor M, Tveit A, Gjesdal K. Mental health and sleep in permanent atrial fibrillation patients from the general population. Clin Cardiol. 2011;34(5):327–31.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Thrall G, Lane D, Carroll D, Lip GY. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med. 2006;119(5):448 e1–19.

    Article  Google Scholar 

  23. Kang Y, Bahler R. Health-related quality of life in patients newly diagnosed with atrial fibrillation. Eur J Cardiovasc Nurs. 2004;3(1):71–6.

    Article  PubMed  Google Scholar 

  24. Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers GM, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol. 2000;36(4):1303–9.

    Article  CAS  PubMed  Google Scholar 

  25. Reed JL, Mark AE, Reid RD, Pipe AL. The effects of chronic exercise training in individuals with permanent atrial fibrillation: a systematic review. Can J Cardiol. 2013;29(12):1721–8.

    Article  PubMed  Google Scholar 

  26. Giacomantonio NB, Bredin SS, Foulds HJ, Warburton DE. A systematic review of the health benefits of exercise rehabilitation in persons living with atrial fibrillation. Can J Cardiol. 2013;29(4):483–91.

    Article  PubMed  Google Scholar 

  27. Risom SS, Zwisler AD, Johansen PP, Sibilitz KL, Lindschou J, Gluud C, et al. Exercise-based cardiac rehabilitation for adults with atrial fibrillation. Cochrane Database Syst Rev. 2017;2:CD011197.

    PubMed  Google Scholar 

  28. Lowres N, Neubeck L, Freedman SB, Briffa T, Bauman A, Redfern J. Lifestyle risk reduction interventions in atrial fibrillation: a systematic review. Eur J Prev Cardiol. 2012;19(5):1091–100.

    Article  PubMed  Google Scholar 

  29. Skielboe AK, Bandholm TQ, Hakmann S, Mourier M, Kallemose T, Dixen U. Cardiovascular exercise and burden of arrhythmia in patients with atrial fibrillation—a randomized controlled trial. PLoS One. 2017;12(2):e0170060.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Abed HS, Wittert GA, Leong DP, Shirazi MG, Bahrami B, Middeldorp ME, et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA. 2013;310(19):2050–60.

    Article  CAS  PubMed  Google Scholar 

  31. Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64(21):2222–31.

    Article  PubMed  Google Scholar 

  32. Pathak RK, Elliott A, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, et al. Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study. J Am Coll Cardiol. 2015;66(9):985–96.

    Article  PubMed  Google Scholar 

  33. Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol. 2015;65(20):2159–69.

    Article  PubMed  Google Scholar 

  34. Rienstra M, Hobbelt AH, Alings M, Tijssen JGP, Smit MD, Brugemann J, et al. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial. Eur Heart J. 2018;01:01.

    Google Scholar 

  35. Risom SS, Zwisler AD, Rasmussen TB, Sibilitz KL, Madsen TLS, Svendsen JH, et al. Cardiac rehabilitation versus usual care for patients treated with catheter ablation for atrial fibrillation: results of the randomized CopenHeart. Am Heart J. 2016;181:120–9.

    Article  PubMed  Google Scholar 

  36. Wagner MK, Zwisler ADO, Risom SS, Svendsen JH, Christensen AV, Berg SK. Sex differences in health status and rehabilitation outcomes in patients with atrial fibrillation treated with ablation: results from the CopenHeartRFA trial. Eur J Cardiovasc Nurs. 2018;17(2):123–35.

    Article  PubMed  Google Scholar 

  37. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.

    Article  PubMed  Google Scholar 

  38. Chatterjee S, Sardar P, Lichstein E, Mukherjee D, Aikat S. Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis. Pacing Clin Electrophysiol. 2013;36(1):122–33.

    Article  PubMed  Google Scholar 

  39. Meyer T, Lauschke J, Ruppert V, Richter A, Pankuweit S, Maisch B. Isolated cardiac sarcoidosis associated with the expression of a splice variant coding for a truncated BTNL2 protein. Cardiology. 2008;109(2):117–21.

    Article  PubMed  Google Scholar 

  40. Allessie M, Ausma J, Schhotten U. Electrical, contractile and structural remodelling during atrial fibrillation. Cardiovasc Res. 2002;54(2):230–46.

    Article  CAS  PubMed  Google Scholar 

  41. Haegeli L. CardioPulse. Percutaneous radiofrequency catheter ablation of atrial fibrillation. Eur Heart J. 2012;33(21):2625–7.

    PubMed  Google Scholar 

  42. Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol. 2009;2(4):349–61.

    Article  CAS  PubMed  Google Scholar 

  43. Ganesan AN, Shipp NJ, Brooks AG, Kuklik P, Lau DH, Lim HS, et al. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(2):e004549.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Williams JM, Ungerleider RM, Lofland GK, Cox JL. Left atrial isolation: new technique for the treatment of supraventricular arrhythmias. J Thorac Cardiovasc Surg. 1980;80(3):373–80.

    CAS  PubMed  Google Scholar 

  45. Cox JL. The surgical treatment of atrial fibrillation. IV. Surgical technique. J Thorac Cardiovasc Surg. 1991;101(4):584–92.

    CAS  PubMed  Google Scholar 

  46. Damiano RJ Jr, Gaynor SL, Bailey M, Prasad S, Cox JL, Boineau JP, et al. The long-term outcome of patients with coronary disease and atrial fibrillation undergoing the Cox Maze procedure. J Thorac Cardiovasc Surg. 2003;126(6):2016–21.

    Article  PubMed  Google Scholar 

  47. Ballaux PK, Geuzebroek GS, van Hemel NM, Kelder JC, Dossche KM, Ernst JM, et al. Freedom from atrial arrhythmias after classic Maze III surgery: a 10-year experience. J Thorac Cardiovasc Surg. 2006;132(6):1433–40.

    Article  PubMed  Google Scholar 

  48. Fragakis N, Pantos I, Younis J, Hadjipavlou M, Katritsis DG. Surgical ablation for atrial fibrillation. Europace. 2012;14(11):1545–52.

    Article  PubMed  Google Scholar 

  49. Wolf RK, Schneeberger EW, Osterday R, Miller D, Merrill W, Flege JB Jr, et al. Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg. 2005;130(3):797–802.

    Article  PubMed  Google Scholar 

  50. Boersma LV, Castella M, van Boven W, Berruezo A, Yilmaz A, Nadal M, et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation. 2012;125(1):23–30.

    Article  PubMed  Google Scholar 

  51. Cox JL. Intraoperative options for treating atrial fibrillation associated with mitral valve disease. J Thorac Cardiovasc Surg. 2001;122(2):212–5.

    Article  CAS  PubMed  Google Scholar 

  52. Kong MH, Lopes RD, Piccini JP, Hasselblad V, Bahnson TD, Al-Khatib SM. Surgical Maze procedure as a treatment for atrial fibrillation: a meta-analysis of randomized controlled trials. Cardiovasc Ther. 2010;28(5):311–26.

    Article  PubMed  Google Scholar 

  53. Kimura K, Tanabe-Hayashi Y, Noma S, Fukuda K. Images in cardiovascular medicine. Rapid formation of left ventricular giant thrombus with Takotsubo cardiomyopathy. Circulation. 2007;115(23):e620–e1.

    Article  PubMed  Google Scholar 

  54. Driver K, Mangrum JM. Hybrid approaches in atrial fibrillation ablation: why, where and who? J Thorac Dis. 2015;7(2):159–64.

    PubMed  PubMed Central  Google Scholar 

  55. Khoynezhad A, Ellenbogen KA, Al-Atassi T, Wang PJ, Kasirajan V, Wang X, et al. Hybrid atrial fibrillation ablation: current status and a look ahead. Circ Arrhythm Electrophysiol. 2017;10(10):pii:e005263.

    Article  Google Scholar 

  56. Jiang YQ, Tian Y, Zeng LJ, He SN, Zheng ZT, Shi L, et al. The safety and efficacy of hybrid ablation for the treatment of atrial fibrillation: A meta-analysis. PLoS One. 2018;13(1):e0190170.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  57. Blackshear J, Odell J. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61(2):755–9.

    Article  CAS  PubMed  Google Scholar 

  58. Sherwood MW, Nessel CC, Hellkamp AS, Mahaffey KW, Piccini JP, Suh EY, et al. Gastrointestinal bleeding in patients with atrial fibrillation treated with rivaroxaban or warfarin: ROCKET AF trial. J Am Coll Cardiol. 2015;66(21):2271–81.

    Article  CAS  PubMed  Google Scholar 

  59. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–51.

    Article  CAS  PubMed  Google Scholar 

  60. Maura G, Blotiere PO, Bouillon K, Billionnet C, Ricordeau P, Alla F, et al. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study. Circulation. 2015;132(13):1252–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial. Circulation. 2013;127(6):720–9.

    Article  PubMed  Google Scholar 

  62. Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1–12.

    Article  PubMed  Google Scholar 

  63. Tzikas A, Shakir S, Gafoor S, Omran H, Berti S, Santoro G, et al. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER cardiac plug. EuroIntervention. 2016;11(10):1170–9.

    Article  PubMed  Google Scholar 

  64. Lehmann LH, Riess H, Sturm I. Sickle cell disease, pulmonary hypertension, and sarcoidosis. Ann Hematol. 2008;87(7):591–2.

    Article  PubMed  Google Scholar 

  65. Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, Sugisaki K, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J. 2008;31(2):372–9.

    Article  CAS  PubMed  Google Scholar 

  66. Shigemitsu H, Nagai S, Sharma OP. Pulmonary hypertension and granulomatous vasculitis in sarcoidosis. Curr Opin Pulm Med. 2007;13(5):434–8.

    Article  PubMed  Google Scholar 

  67. Kusa S, Miller MA, Whang W, Enomoto Y, Panizo JG, Iwasawa J, et al. Outcomes of ventricular tachycardia ablation using percutaneous left ventricular assist devices. Circ Arrhythm Electrophysiol. 2017;10(6):pii:e004717.

    Article  Google Scholar 

  68. Maury P, Leobon B, Duparc A, Delay M, Galinier M. Epicardial catheter ablation of ventricular tachycardia using surgical subxyphoid approach. Europace. 2007;9(4):212–5.

    Article  CAS  PubMed  Google Scholar 

  69. Baughman RP, Lower EE. Six-minute walk test in managing and monitoring sarcoidosis patients. Curr Opin Pulm Med. 2007;13(5):439–44.

    Article  PubMed  Google Scholar 

  70. Thiene G, Corrado D, Basso C. Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Orphanet J Rare Dis. 2007;2:45.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Anter E, Hutchinson MD, Deo R, Haqqani HM, Callans DJ, Gerstenfeld EP, et al. Surgical ablation of refractory ventricular tachycardia in patients with nonischemic cardiomyopathy. Circ Arrhythm Electrophysiol. 2011;4(4):494–500.

    Article  PubMed  Google Scholar 

  72. Liang JJ, Betensky BP, Muser D, Zado ES, Anter E, Desai ND, et al. Long-term outcome of surgical cryoablation for refractory ventricular tachycardia in patients with non-ischemic cardiomyopathy. Europace. 2018;20(3):e30–41.

    Article  PubMed  Google Scholar 

  73. Ziv O, Dizon J, Thosani A, Naka Y, Magnano AR, Garan H. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol. 2005;45(9):1428–34.

    Article  PubMed  Google Scholar 

  74. Shirazi JT, Lopshire JC, Gradus-Pizlo I, Hadi MA, Wozniak TC, Malik AS. Ventricular arrhythmias in patients with implanted ventricular assist devices: a contemporary review. Europace. 2013;15(1):11–7.

    Article  PubMed  Google Scholar 

  75. Bedi M, Kormos R, Winowich S, McNamara DM, Mathier MA, Murali S. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol. 2007;99(8):1151–3.

    Article  PubMed  Google Scholar 

  76. Sacher F, Reichlin T, Zado ES, Field ME, Viles-Gonzalez JF, Peichl P, et al. Characteristics of ventricular tachycardia ablation in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol. 2015;8(3):592–7.

    Article  PubMed  Google Scholar 

  77. Raissi Shabari F, Yousef J, Cohn W, Gregoric I, Frazier OH, Cheng J, et al. Open chest epicardial ablation of ventricular tachycardia early after left ventricular assist device implantation. J Heart Lung Transplant. 2013;32(4):S272.

    Article  Google Scholar 

  78. Herweg B, Ilercil A, Kristof-Kuteyeva O, Rinde-Hoffman D, Caldeira C, Mangar D, et al. Clinical observations and outcome of ventricular tachycardia ablation in patients with left ventricular assist devices. Pacing Clin Electrophysiol. 2012;35(11):1377–83.

    Article  PubMed  Google Scholar 

  79. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm. 2013;10(12):e85–108.

    Article  PubMed  Google Scholar 

  80. Nunn LM, Lambiase PD. Genetics and cardiovascular disease—causes and prevention of unexpected sudden adult death: the role of the SADS clinic. Heart. 2011;97(14):1122–7.

    Article  CAS  PubMed  Google Scholar 

  81. Behr ER, Dalageorgou C, Christiansen M, Syrris P, Hughes S, Tome Esteban MT, et al. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J. 2008;29(13):1670–80.

    Article  PubMed  Google Scholar 

  82. Hendriks KS, Hendriks MM, Birnie E, Grosfeld FJ, Wilde AA, van den Bout J, et al. Familial disease with a risk of sudden death: a longitudinal study of the psychological consequences of predictive testing for long QT syndrome. Heart Rhythm. 2008;5(5):719–24.

    Article  PubMed  Google Scholar 

  83. Christiaans I, van Langen IM, Birnie E, Bonsel GJ, Wilde AA, Smets EM. Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. Am J Med Genet A. 2009;149A(4):602–12.

    Article  PubMed  Google Scholar 

  84. Adler A, Sadek MM, Chan AY, Dell E, Rutberg J, Davis D, et al. Patient outcomes from a specialized inherited arrhythmia clinic. Circ Arrhythm Electrophysiol. 2016;9(1):e003440.

    Article  PubMed  Google Scholar 

  85. Barry MJ, Edgman-Levitan S. Shared decision making—pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780–1.

    Article  CAS  PubMed  Google Scholar 

  86. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997;44(5):681–92.

    Article  CAS  PubMed  Google Scholar 

  87. Makoul G, Clayman ML. An integrative model of shared decision making in medical encounters. Patient Educ Couns. 2006;60(3):301–12.

    Article  PubMed  Google Scholar 

  88. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):e199–267.

    PubMed  PubMed Central  Google Scholar 

  89. Masoudi FA, Calkins H, Kavinsky CJ, Drozda JP Jr, Gainsley P, Slotwiner DJ, et al. 2015 ACC/HRS/SCAI left atrial appendage occlusion device societal overview. Heart Rhythm. 2015;12(10):e122–36.

    Article  PubMed  Google Scholar 

  90. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(14):1677–749.

    Article  PubMed  Google Scholar 

  91. Bennett M, Parkash R, Nery P, Senechal M, Mondesert B, Birnie D, et al. Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 implantable cardioverter-defibrillator guidelines. Can J Cardiol. 2017;33:174–88.

    Article  PubMed  Google Scholar 

  92. Lampert R, Hayes DL, Annas GJ, Farley MA, Goldstein NE, Hamilton RM, et al. HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm. 2010;7(7):1008–26.

    Article  PubMed  Google Scholar 

  93. Stacey D, Legare F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;4:CD001431.

    PubMed  Google Scholar 

  94. Legare F, Stacey D, Turcotte S, Cossi MJ, Kryworuchko J, Graham ID, et al. Interventions for improving the adoption of shared decision making by healthcare professionals. Cochrane Database Syst Rev. 2014;9:CD006732.

    Google Scholar 

  95. Kinnersley P, Edwards A, Hood K, Ryan R, Prout H, Cadbury N, et al. Interventions before consultations to help patients address their information needs by encouraging question asking: systematic review. BMJ. 2008;337:a485.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Stacey D, Kryworuchko J, Belkora J, Davison BJ, Durand MA, Eden KB, et al. Coaching and guidance with patient decision aids: a review of theoretical and empirical evidence. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S11.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Elwyn G, O’Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333(7565):417.

    Article  PubMed  PubMed Central  Google Scholar 

  98. O’Neill ES, Grande SW, Sherman A, Elwyn G, Coylewright M. Availability of patient decision aids for stroke prevention in atrial fibrillation: a systematic review. Am Heart J. 2017;191:1–11.

    Article  PubMed  Google Scholar 

  99. Probst MA, Noseworthy PA, Brito JP, Hess EP. Shared decision-making as the future of emergency cardiology. Can J Cardiol. 2018;34(2):117–24.

    Article  PubMed  Google Scholar 

  100. Jensen T, Chin J, Ashby L, Long K, Schafer J, Hakim R. Decision memo for percutaneous left atrial appendage (LAA) closure therapy (CAG-00445N). 2016.

    Google Scholar 

  101. Institute PCOR. $5 million award from PCORI and AHA establishes center to support better-informed AFib treatment decisions. June 18, 2018. Available from: https://www.pcori.org/news-release/5-million-award-pcori-and-aha-establishes-center-support-better-informed-afib-treatment.

  102. Carroll SL, Stacey D, McGillion M, Healey JS, Foster G, Hutchings S, et al. Evaluating the feasibility of conducting a trial using a patient decision aid in implantable cardioverter defibrillator candidates: a randomized controlled feasibility trial. Pilot Feasibility Stud. 2017;3:49.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Jenkins A, Jones J, Mellis BK, Nuanes H, Nowels C, Varosy P, et al. Development and pilot of four decision aids for implantable cardioverter-defibrillators in different media formats. 37th annual meeting of the Society for Medical Decision Making; St Louis, Missouri. 2015.

    Google Scholar 

  104. Lewis KB, Birnie D, Carroll SL, Clark L, Kelly F, Gibson P, et al. User-centered development of a decision aid for patients facing implantable cardioverter-defibrillator replacement: a mixed-methods study. J Cardiovasc Nurs. 2018;33(5):481–91.

    Article  PubMed  Google Scholar 

  105. When to consider implantable cardioverter defibrillator (ICD) deactivation: a guide for patients and family. Toronto, ON: CorHealth; 2018.

    Google Scholar 

  106. Implantable cardioverter defibrillator deactivation: a guide for health care professionals. Toronto, ON: Cardiac Care Network; 2017.

    Google Scholar 

  107. Legare F, Stacey D, Forest PG, Coutu MF, Archambault P, Boland L, et al. Milestones, barriers and beacons: shared decision making in Canada inches ahead. Z Evid Fortbild Qual Gesundhwes. 2017;123–124:23–7.

    Article  PubMed  Google Scholar 

  108. Elwyn G, Scholl I, Tietbohl C, Mann M, Edwards AG, Clay C, et al. “Many miles to go …”: a systematic review of the implementation of patient decision support interventions into routine clinical practice. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S14.

    Article  PubMed  PubMed Central  Google Scholar 

  109. Joseph-Williams N, Lloyd A, Edwards A, Stobbart L, Tomson D, Macphail S, et al. Implementing shared decision making in the NHS: lessons from the MAGIC programme. BMJ. 2017;357:j1744.

    Article  PubMed  PubMed Central  Google Scholar 

  110. Friedman DJ, Al-Khatib SM. Measuring quality in electrophysiology. J Interv Card Electrophysiol. 2016;47:5–10.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Society CC. Quality project. Available from: http://www.ccs.ca/en/health-policy/programs-and-initiatives/quality-project. Accessed 20 July 2017.

  112. Mehaffey JH, Hawkins RB, Byler M, Smith J, Kern JA, Kron I, et al. Amiodarone protocol provides cost-effective reduction in postoperative atrial fibrillation. Ann Thorac Surg. 2018;105(6):1697–702.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lancashire Cardiac Centre, Department of Cardiac Electrophysiology, Blackpool, UK

    Mark Ainslie

  2. University of Ottawa Heart Institute, Department of Exercise Physiology and Cardiovascular Health Lab, Division of Cardiac Prevention and Rehabilitation, Ottawa, ON, Canada

    Jennifer L. Reed

  3. University of Ottawa School of Nursing, Ottawa, ON, Canada

    Krystina B. Lewis

  4. Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada

    David Hugh Birnie

Authors
  1. Mark Ainslie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer L. Reed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Krystina B. Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Hugh Birnie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Hugh Birnie .

Editor information

Editors and Affiliations

  1. University of Ottawa Heart Institute, Ottawa, ON, Canada

    Thierry Mesana

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ainslie, M., Reed, J.L., Lewis, K.B., Birnie, D.H. (2019). Do We Need Heart Teams for Complex Cardiac Arrhythmias? A Cardiologist’s Perspective. In: Mesana, T. (eds) Heart Teams for Treatment of Cardiovascular Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-19124-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-19124-5_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-19123-8

  • Online ISBN: 978-3-030-19124-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation